CN103965303A - Marine bacillus licheniformis protein and application thereof to cardiovascular field - Google Patents

Marine bacillus licheniformis protein and application thereof to cardiovascular field Download PDF

Info

Publication number
CN103965303A
CN103965303A CN201310034684.2A CN201310034684A CN103965303A CN 103965303 A CN103965303 A CN 103965303A CN 201310034684 A CN201310034684 A CN 201310034684A CN 103965303 A CN103965303 A CN 103965303A
Authority
CN
China
Prior art keywords
bacillus licheniformis
dnn6
dialysis
protein
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310034684.2A
Other languages
Chinese (zh)
Inventor
张付云
徐凤
杨阳
王维才
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Ocean University
Original Assignee
Dalian Ocean University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Ocean University filed Critical Dalian Ocean University
Priority to CN201310034684.2A priority Critical patent/CN103965303A/en
Publication of CN103965303A publication Critical patent/CN103965303A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A marine bacillus licheniformis protein. A preparation method comprises the following steps: inoculating a kelp endophytic bacillus licheniformis DNN6 strain to a liquid medium, wherein the liquid medium formula comprises 40-50g / L sucrose and 8-10g / L peptone, and has pH value adjusted to 9; bottling 150-250mL of the liquid medium into each bottle, and conducting shaking culture at temperature of 30-35 DEG C, rotating speed of 150-250 rpm for 4-5 days; centrifuging the fermentation liquid at 8000 r / min to remove thalli, then adding ammonium sulfate, wherein the saturation concentration of ammonium sulfate is 95%, and standing overnight at 4 DEG C; and filtering, dissolving the precipitate with distilled water, then conducting dialysis by using a dialysis bag with cut-off molecular weight of 3600 Dalton for 4 days, and conducting freeze-drying on the products in the dialysis bag, so as to obtain the marine endophytic bacillus licheniformis protein. The invention also provides the application of the protein to the cardiovascular field. The process is simple and low in cost.

Description

A kind of ocean Bacillus licheniformis albumen and application aspect cardiovascular thereof
Technical field
The present invention relates to field of medicaments, particularly raw Bacillus licheniformis DNN6(in a main laminaria bacillus licheniformisdNN6) strain protein and the application aspect cardiovascular.
Background technology
Sea-tangle ( laminaria Japonicaaresch) be a kind of raw brown alga plant in large-scale sea growing in low temperature seawater.It grows in lower marine of water temperature.Sea-tangle is mainly self-sow, also propagates artificially, mainly with dry products, is on sale throughout in city, and quality take that look brown, body is short, the thin and plump person of matter is as good.Sea-tangle has the good reputation of " longevity greens/mustard green ", " vegetables at sea " " containing iodine champion ".
Sea-tangle is as a kind of important oceanic resources, and it eats with pharmaceutical use and is early in the public eye.That the effective constituent of extracting from sea-tangle has is hypoglycemic, reducing blood-fat, antitumor, anti-HIV and strengthen immunologic function, to treatment cardiovascular and cerebrovascular diseases and in, early stage chronic kidney hypofunction etc. all has certain effect.In sea-tangle, also contain some attached microorganisms altogether, but these microorganisms and meta-bolites thereof are not only also fully utilized so far.
Summary of the invention
The object of this invention is to provide raw Bacillus licheniformis DNN6(in a kind of sea-tangle simple to operate, with low cost bacillus licheniformisdNN6) strain protein and the application aspect cardiovascular thereof, to make full use of the common attached microorganism of sea-tangle, overcome the deficiencies in the prior art.
A kind of ocean of the present invention Bacillus licheniformis albumen, as follows preparation:
A. get raw Bacillus licheniformis DNN6(Bacillus licheniformis DNN6 in sea-tangle), this bacterial strain has been preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC), preserving number: CGMCC No:7077 on December 31st, 2012;
B. Bacillus licheniformis DNN6 is inoculated in liquid nutrient medium, the formula of this liquid nutrient medium is: sucrose 40-50 g/L and peptone 8-10 g/L, and pH is deployed into 9;
C. b step finishes rear packing, every bottled 100-200 mL liquid nutrient medium, and temperature 30-35 ℃, rotating speed is 150-200 rpm, shaking table is cultivated 4-5 days;
D. by the fermented liquid of c step centrifugal treating under the condition of 8000 r/min, remove thalline, then add ammonium sulfate, the saturated final concentration of ammonium sulfate is 95%, 4 ℃ of standing over night, filter and will precipitate with after distilled water dissolving, then are 3600 daltonian dialysis tubings dialysis 4 days with molecular weight cut-off, get thing lyophilize in dialysis tubing, obtain ocean Bacillus licheniformis albumen.
The application of a kind of ocean of the present invention Bacillus licheniformis albumen aspect cardiovascular.
Ocean of the present invention Bacillus licheniformis protein preparation method technique is simple, with low cost, the albumen extracting the fermented liquid of raw lichem bacillus strain in sea-tangle has hypotensive activity, the development and the exploitation that can be applicable to Altace Ramipril, have industrial value.
The ocean lichem bacillus strain of applying in the present invention has been preserved in the China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC) that is positioned at No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, preserving number: CGMCC No:7077 on December 31st, 2012.
embodiment
The embodiment of the present invention is carried out successively as follows:
A. strain Bacillus licheniformis DNN6 is inoculated in to sucrose 40-50 g/L and peptone 8-10 g/L, in the liquid nutrient medium that pH is 9, every bottled 100-200 mL liquid nutrient medium, temperature 30-35 ℃, rotating speed is 150-200 rpm, shaking table is cultivated 4-5 days.This lichem bacillus strain has been preserved in the China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC) that is positioned at No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, preserving number: CGMCC No:7077 on December 31st, 2012.
B. by the centrifugal removal thalline of fermented liquid 8000 r/min, then add ammonium sulfate, the saturated final concentration of ammonium sulfate is 95%, 4 ℃ of standing over night, filter and will precipitate with after distilled water dissolving, then be 3600 daltonian dialysis tubings dialysis 4 days with molecular weight cut-off, get thing lyophilize in dialysis tubing, obtain ocean Bacillus licheniformis albumen, SDS-PAGE electrophoresis result shows that this throw out is protein.
Get freeze-drying sample and with PBS solution, be dissolved into the solution of 1 mg/mL, use respectively the dosage of 180 mg/kg and 18 mg/kg, jugular vein administration SD rat (The 2nd Army Medical College Experimental Animal Center provides), two dosage all can make systolic pressure decline 3.17 ± 0.1 KPa; Isolated heart pours into the shrinkage amplitude that 18 mg/kg can reduce SD isolated rat heart.
C. the impact on rat blood pressure
Laboratory animal: male SD rat is purchased from The 2nd Army Medical College Experimental Animal Center.Experimental session, keeps Animal House room temperature 22 ℃ of left and right, relative humidity 70% left and right, early 8 extremely late 8 automatic illuminatings.Animal ad lib, freely drinks water.
The preparation of ductus arteriosus: PE10(internal diameter 0.3 cm, external diameter 0.5 cm) and PE50(internal diameter 0.58 mm, external diameter 0.96 mm) two kinds of specification conduits are prepared ductus arteriosus, PE10 pipe is docked by thin wire with PE50 pipe, after heating, press the protuberance that joint forms, cooling rear extraction iron wire, can apply after inspection joint is firm, unobstructed.
20% urethanum (urethane), 5 mL/kg intraperitoneal anesthesia rats, lain on the back and be fixed on animal constant temperature autopsy table, a separated side femoral artery, distal end ligation, proximal part inserts the arterial cannulation of filling with 1% heparin-saline, the opposite side connecting tee pipe of intubate is by by PowerLab MLT1199 invasive blood pressure measuring system, dynamically recording arteriotony.After blood pressure stabilization, by jugular vein intubate, to DNN6 strain protein (180 mg/kg and 18 mg/kg), and recording blood pressure changes.Experimental result shows that two dosage all can make systolic pressure decline 3.17 ± 0.1 KPa, have the potentiality of exploitation depressor.
D. the foundation of Isolated Rat heart model: by SD for rat after urethane (1.2 gkg-1) and heparin (400 IUkg-1) mixed solution intraperitoneal anesthesia, opening rapidly chest cores, by classical Langendorff method, through aorta ascendens, drive in the wrong direction and insert intrusion pipe, make it be placed in aortic valve top, in order to coronary perfusion.Adopt KH liquid to carry out balance perfusion, when front 30 min of perfusion and perfusion, fill with mixed gas (95% O2+5% CO2), make the KH liquid of balance perfusion fully reach oxygen saturation, pH value maintains 7.35 ~ 7.45, keeping filling temperature is 37.0 ℃ ~ 37.5 ℃, and injection pressure is 60 mmHg.Two suspension electrocardiographic recording electrodes are positioned over to pulmonary conus respectively and apex is guided out electrocardiogram(ECG, and the cardiac function index such as recorded heart rate.Experimental result shows 4 min after the K-H liquid perfusion heart of the albumen (18 mg/kg) with containing bacterial strain DNN6, and heart contraction amplitude reduces by 23%.With K-H liquid, recover after perfusion, heart contraction amplitude and rest tension recover gradually again.The hypotensive activity of bacterial strain DNN6 albumen may be relevant with reduction heart function.

Claims (2)

1. an ocean Bacillus licheniformis albumen, is characterized in that: preparation as follows:
A. get raw Bacillus licheniformis DNN6(in sea-tangle bacillus licheniformisdNN6), this bacterial strain was preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC), preserving number: CGMCC No:7077 on January 10th, 2013;
B. Bacillus licheniformis DNN6 is inoculated in liquid nutrient medium, the formula of this liquid nutrient medium is: sucrose 40-50 g/L and peptone 8-10 g/L, and pH is deployed into 9;
C. b step finishes rear packing, every bottled 100-200 mL liquid nutrient medium, and temperature 30-35 ℃, rotating speed is 150-200 rpm, shaking table is cultivated 4-5 days;
D. by the fermented liquid of c step centrifugal treating under the condition of 8000 r/min, remove thalline, then add ammonium sulfate, the saturated final concentration of ammonium sulfate is 95%, 4 ℃ of standing over night, filter and will precipitate with after distilled water dissolving, then are 3600 daltonian dialysis tubings dialysis 4 days with molecular weight cut-off, get thing lyophilize in dialysis tubing, obtain ocean Bacillus licheniformis albumen.
2. the application of ocean according to claim 1 Bacillus licheniformis albumen aspect cardiovascular.
CN201310034684.2A 2013-01-30 2013-01-30 Marine bacillus licheniformis protein and application thereof to cardiovascular field Pending CN103965303A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310034684.2A CN103965303A (en) 2013-01-30 2013-01-30 Marine bacillus licheniformis protein and application thereof to cardiovascular field

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310034684.2A CN103965303A (en) 2013-01-30 2013-01-30 Marine bacillus licheniformis protein and application thereof to cardiovascular field

Publications (1)

Publication Number Publication Date
CN103965303A true CN103965303A (en) 2014-08-06

Family

ID=51235349

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310034684.2A Pending CN103965303A (en) 2013-01-30 2013-01-30 Marine bacillus licheniformis protein and application thereof to cardiovascular field

Country Status (1)

Country Link
CN (1) CN103965303A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008088493A2 (en) * 2006-12-21 2008-07-24 Danisco Us, Inc., Genencor Division Compositions and uses for an alpha-amylase polypeptide of bacillus species 195
CN100463919C (en) * 2006-11-15 2009-02-25 江苏省农业科学院 Extracellular antiseptic protein for Bacillus subtilis and its separation and purification method
CN102102082A (en) * 2010-12-16 2011-06-22 大连海洋大学 Method for separating and purifying endogenous active strains in kelp

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100463919C (en) * 2006-11-15 2009-02-25 江苏省农业科学院 Extracellular antiseptic protein for Bacillus subtilis and its separation and purification method
WO2008088493A2 (en) * 2006-12-21 2008-07-24 Danisco Us, Inc., Genencor Division Compositions and uses for an alpha-amylase polypeptide of bacillus species 195
CN102102082A (en) * 2010-12-16 2011-06-22 大连海洋大学 Method for separating and purifying endogenous active strains in kelp

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杨阳等: "地衣芽胞杆菌生物活性物质应用研究进展", 《生物技术进展》, vol. 3, no. 1, 25 January 2013 (2013-01-25), pages 22 - 26 *

Similar Documents

Publication Publication Date Title
CN103330258B (en) Cordyceps militaris health-care beverage prepared by liquid submerged fermentation and preparation method thereof
CN104940644A (en) Method for fermenting dendrobium officinale employing lactic acid bacteria, as well as fermented product and application of dendrobium officinale
CN100484963C (en) Exo-polysaccharide of lactobacillus casei and crude product, prepartion method and application
CN106916861B (en) Method for simultaneously producing auricularia auricula polysaccharide and melanin
CN108244432A (en) A kind of fermentation Cordyceps militaris probiotic beverage and preparation method thereof
CN108669501A (en) A kind of fermentation pickled vegetable and preparation method thereof of low nitrite high dietary-fiber
CN107937311B (en) Streptococcus thermophilus for high yield of gamma-aminobutyric acid, preservation and culture method and method for preparing fermented milk by using streptococcus thermophilus
CN113966832A (en) Dendrobium nobile fermentation product and preparation method and application thereof
CN107853690A (en) A kind of fermentation process of the beautiful ferment of promise
CN103478839A (en) Glucan beverage and preparation method thereof
CN103229831A (en) Preparation method of high-calcium goat yogurt fermented by lactobacillus plantarum containing ACE (Angiotensin Converting Enzyme) inhibitory peptides
CN106722942A (en) The preparation method of moringa enzyme
CN106721770A (en) Using the method for the red jujube prebiotic beverage of preparation ferment
CN111117894A (en) Aspergillus oryzae strain and application thereof
CN110656151A (en) Method for improving kidney-tonifying and yang-strengthening effects of sea cucumber
CN104277962B (en) A kind of two-step fermentation prepares the method for Vinegar Beverage of Ganoderma Lucidum
CN102399840A (en) Culture medium formulation for fermenting rainbow conk high-yield EPS and application thereof in cigarettes
CN102660439A (en) Sea-buckthorn ice wine and making method thereof
CN111334440A (en) Rhizopus oryzae CH5 and application thereof in extraction of ganoderma sinensis polysaccharide
CN107488616A (en) Strain, probiotics facial mask, the preparation method of health preserving fungi bacterium tea and edible fungi tea
CN113186069A (en) Lactobacillus strain microbial fermentation process
CN103222505A (en) Preparation method of lactobacillus plantarum fermented goat milk containing ACE inhibitory peptide
CN112704230A (en) Agar oligosaccharide powder product and application thereof
CN103965303A (en) Marine bacillus licheniformis protein and application thereof to cardiovascular field
CN101168762B (en) Method for preparing antihypertensive peptide from hairtail backbone by fermentation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140806